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Fas ligand is a well-known inducer of apoptosis in cells
expressing its receptor Fas; it also prevents autoimmunity
by inducing apoptosis of activated T cells. However,
Fas ligand also mediates non-apoptotic functions involving
inflammatory cell migration and cytokine responses. We
sought here to study the role of Fas ligand in nephrotoxic
nephritis, a model of crescentic glomerulonephritis, using
generalized lymphoproliferative disorder (GLD) mice on a
C57BL/6 background, which have defective Fas ligand and
display only mild autoimmunity. These mice were
significantly protected from glomerular crescent formation,
glomerular thrombosis, renal impairment, and albuminuria
15 days after the induction of glomerulonephritis in
comparison with wild-type mice. There were a reduced
number of apoptotic cells in the glomeruli of nephritic GLD
mice but no defect in their antibody responses or splenocyte
proliferation at 15 days following the induction of
glomerulonephritis. Bone marrow transplantation from wild-
type mice restored disease susceptibility to GLD mice;
however, wild-type mice were not protected when
transplanted with bone marrow from GLD mice. Mesangial
cells express Fas ligand in vitro, and these cells isolated from
GLD mice produced lower amounts of monocyte
chemoattractive protein-1 following interleukin-1 stimulation
compared with cells from wild-type mice. Thus, Fas ligand-
defective mice are protected from nephrotoxic nephritis, a
disease in which both circulating and intrinsic renal cells
appear to have a role.
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Fas ligand (FasL, CD95L) belongs to the tumor necrosis
factor (TNF) family, and has a well-characterized role in
inducing apoptosis in target cells by crosslinking the receptor,
Fas (CD95), on the cell surface.1 Deficiency of FasL can lead
to autoimmunity in humans and mice on certain genetic
backgrounds, due to the lack of activation-induced cell death
of T lymphocytes.2 However, paradoxically, deficiency of FasL
has also been associated with protection from inflammation.
FasL is involved in apoptosis of mesangial cells by macro-
phages.3 Non-apoptotic functions of FasL including cell
survival and migration, nuclear factor kappa B activation,
and cytokine release are increasingly recognized.4,5 Soluble
FasL has been implicated in chemotaxis of neutrophils and
monocytes.6–8 FasL also has been implicated in facilitating the
release of cytokines such as monocyte chemoattractive
protein (MCP)-1, interleukin (IL)-6, and IL-12 in response
to IL-1 and Toll-like receptor 4 stimulation.9–11
FasL is expressed in the kidney in human glomerulone-
phritis and animal models of glomerulonephritis,12,13 but its
functional effects are not known. We therefore set out to
determine the role of FasL in nephrotoxic nephritis and to
determine the relative roles of FasL expression on circulating
and intrinsic renal cells.
Generalized lymphoproliferative disorder (GLD) mice
have a defective form of FasL with a point mutation in the
extracellular region of FasL,2,14 affecting the binding of
the protein to Fas. On permissive genetic backgrounds (for
example, MRL), GLD mice developed lymphadenopathy,
splenomegaly, and autoimmunity. However, in other strains
(for example, C57BL/6), a defective Fas/FasL system induced
autoantibodies, but only mild glomerulonephritis.15 We have
used mice on a C57BL/6 background for these studies.
RESULTS
GLD mice on a C57BL/6 background developed glomerular
immune complex deposition, but no significant renal
damage during the time course of the NTN experiments
Mice used in the nephrotoxic nephritis (NTN) experiments
were between 2 and 4 months of age. We therefore
investigated GLD mice of these ages for evidence of
spontaneous renal disease. At 2 months, histology and
immunofluorescence of the GLD mice were normal. At
4 months, there was some granular immunoglobulin (Ig)G
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deposited in the glomeruli, but the kidneys were histologi-
cally normal (Supplementary Figure S1 online). There was no
albuminuria or renal dysfunction in any of the groups and no
significant difference in glomerular macrophage numbers
between GLD and WT at 2 and 4 months (Table 1). There
were no crescents or glomerular thrombosis in unmanipu-
lated wild-type (WT) and GLD mice at 2 and 4 months.
GLD mice were protected from renal injury in NTN
Nephrotoxic nephritis was induced in GLD mice and WT
C57BL/6 controls. Mice were killed at Day 8 and Day 15 after
the induction of disease (Figures 1 and 2 (Day 15) and
Supplementary Figure S2 online (Day 8)). FasL-defective GLD
mice were strongly protected from renal injury compared
with WT mice, in terms of glomerular thrombosis (Po0.01),
glomerular crescents (Po0.001), albuminuria (Po0.001),
serum albumin (Po0.001), and serum urea (Po0.01). TUNEL
staining revealed lower numbers of glomerular apoptotic cells
in the GLD than in the WTmice (Po0.001; Figure 1f).
There was no reduction in glomerular neutrophil or
macrophage infiltration, but interstitial inflammation was
reduced in GLD mice
Despite protection from injury, the GLD mice had a
macrophage infiltrate in the glomeruli that was not
significantly different from WT nephritic mice (median
1.86 versus 1.24 CD68-positive cells/glomerular cross-section
in WT versus GLD, not significant; Figures 2 and 3a). In
contrast, in the interstitial regions, there was a reduction in
the macrophage infiltration in the GLD mice compared with
WT (Po0.01, Figures 2 and 3b). This was mirrored by
reduced MCP-1 mRNA in whole-kidney mRNA extracts at
Day 15 (Figure 3c, Po0.001). At 24 h after injection of
nephrotoxic serum, there was no significant difference in the
glomerular neutrophil infiltrate between WT and GLD mice
(Figure 3d), although there was a wide range, possibly
because of the transient nature of the neutrophil population.
Antibody and T-cell responses to the nephritogenic antigen
To determine the mechanism for the protection of disease,
the systemic and local immune responses were analyzed.
Murine IgG deposited in glomeruli was quantified at Day 1,
Day 8, and Day 15 after the induction of disease. Compared
with WT, there was a delay in the glomerular antibody
deposition in GLD mice, as there was significantly less in
GLD glomeruli at Day 1 (Po0.01), no difference at Day 8
and more mouse IgG (Po0.01) deposited at Day 15 after
induction of disease (Figure 4a). Similarly, in terms of
circulating mouse anti-sheep IgG, there was no significant
difference between WTand GLD at Day 1, but relative to WT,
there was significantly more circulating anti-sheep IgG at Day
8 and Day 15 in the GLD mice (Po0.05 and Po0.01,
respectively; Figure 4b).
Splenocyte proliferation to sheep IgG was determined
after preimmunization only (primary immune response) and
in a separate experiment at the termination (Day 10). There
was reduced splenocyte proliferation to antigen in the GLD
mice after preimmunization alone (Figure 5a); however, by
Table 1 | Control data: unmanipulated mice
WT (n=8) GLD (n=8) WT (n=8) GLD (n=8)
Age (in months) 2 2 4 4
Glomerular mouse IgG Negative Negative Negative Granular
Serum urea (mmol/l) 9.4 (7.7–11.6) 7.5 (5.8–8.4) 7.2 (6.8–8.9) 11.3 (11.1–12.9)
Serum creatinine (mmol/l) 49.0 (45.5–50.0) 39.5 (37.0–42.5) 42.5 (38.0–49.0) 37.0 (35.0–41.0)
Macrophages/gcs 0.1 (0.02–0.19) 0.12 (0–0.56) 0.33 (0.24–0.044) 0.49 (0.34–0.54)
Urinary albumin/creatinine ratio (mg/mmol) 0.01 (0.01–0.01) 0.01 (0.01–0.01) 0.01 (0.01–0.01) 0.01 (0.01–0.01)
Abbreviations: gcs, glomerular cross-section; GLD, generalized lymphoproliferative disorder; IgG, immunoglobulin G; WT, wild-type.
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Figure 1 | Functional and histological parameters at Day 15
after induction of nephrotoxic nephritis (NTN) in wild-type
(WT) and generalized lymphoproliferative disorder (GLD)
mice. (a) Glomerular thrombosis score, (b) percentage glomerular
crescents, (c) urinary albumin/creatinine ratio (mg/mmol),
(d) serum albumin (g/l), (e) serum urea (mmol/l), (f) apoptotic
bodies/gcs. Dashed lines represent values for a group of normal
WT mice. gcs, glomerular cross-section.
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the end of the experiment, the proliferation was equal
between WT and GLD (Figure 5b). Analysis of cytokines
produced by splenocytes after preimmunization and re-
challenge with sheep IgG in vitro showed reduced interferon
gamma (IFN-g) production by GLD splenocytes (Po0.05)
and a tendency to a reduced IL-17A production (P¼ 0.09;
Figure 5a). In the Day-10 experiment, the supernatant IFN-g
production was below the limit for detection by the enzyme-
linked immunosorbent assay (ELISA). The IL-4 production
by splenocytes in response to sheep IgG was barely above the
detection limit of the assay, and not significantly different
between the two groups. Therefore, there was a defect in
T-cell responses early in the phase of the disease, although
this was not evident at Day 10 post NTN.
To investigate this further, intrarenal T cells and cytokines
were analyzed. There was a reduction in CD4-positive T-cell
infiltration in the GLD mice at Day 15 after induction of
NTN (median 0.38 (interquartile range 0.19–0.57) CD4-
positive T cells/glomerular cross-section in the WT mice
versus 0.19 (0.1–0.23) CD4þ cells/glomerular cross-section
in the GLD mice; Figure 6a). In parallel with this observation,
we saw reduced mRNA for IFN-g in the kidneys of the
nephritic GLD mice (Po0.05, Figure 6b). IL-4 mRNA was
downregulated in nephritic kidneys compared with non-
diseased kidneys, and there was no significant difference
between WT and GLD nephritic mice (Figure 6c). mRNA for
IL-12p40, a component of IL-12 and IL-23, was significantly
reduced in the GLD kidneys compared with WT nephritic
kidneys (Po0.001, Figure 6d). Taken together, there was a
moderate reduction in the systemic T-cell response at an early
stage of NTN, but not at later.
Fas ligand derived from either bone marrow-derived or
radioresistant intrinsic renal cells was sufficient to restore
susceptibility to NTN
Bone marrow transplant experiments were conducted to
compare the role of bone marrow-derived and radioresistant
cell expression of FasL. GLD mice were transplanted with WT
bone marrow and WT mice were transplanted with GLD
bone marrow, as well as isografts performed as controls. To
assess reconstitution of circulating leukocytes, mice were
transplanted with bone marrow marked with the allotype
marker CD45.1 rather than CD45.2, the C57BL/6 allotype.
A median of 92.2% (range 90.9–93.4%) of CD45-positive
circulating leukocytes were of CD45.1 donor origin, as
opposed to the recipient CD45.2 cells in peripheral blood at
8 weeks after bone marrow transplantation (Supplementary
Figure 2 |Histology at Day 15 after induction of nephrotoxic
nephritis (NTN). (a) Periodic acid-Schiff-stained wild-type (WT)
kidney section showing glomerular hypercellularity, and a
glomerular crescent; (b) generalized lymphoproliferative disorder
(GLD) kidney at Day 15 after induction of NTN showing mild
glomerular hypercellularity only. (c, e) Immunoperoxidase staining
for CD68 in WT kidney showing interstitial and glomerular
macrophage infiltration. (d, f) Immunoperoxidase staining for
CD68 in GLD kidney showing glomerular, but little interstitial,
macrophage infiltration. Apoptotic bodies were present in WT
glomeruli (g) but absent from GLD glomeruli by TUNEL
staining (h).
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Figure 3 |Day 15 after induction of NTN. (a) CD68-positive
macrophages/glomerular cross-section (gcs); (b) CD68-positive
macrophage interstitial infiltration assessed by image analysis;
(c) relative expression of MCP-1 mRNA in GLD and WT mice post
nephrotoxic nephritis (NTN) compared with control wild-type
(WT) and generalized lymphoproliferative disorder (GLD) mice;
(d) neutrophils/gcs 24 h after induction of NTN. Dashed lines
represent values for a group of normal WT mice. MCP, monocyte
chemoattractive protein; ns, not significant.
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Figure S3 online). Semiquantitative PCR of DNA extracted
from whole blood at the termination of the experiments was
compared with a standard curve of known mixtures of WT
and GLD DNA. More than 95% of DNA extracted from
circulating blood was of donor origin in both the WT to GLD
and the GLD to WT transplants (not shown).
Ten weeks post bone marrow transplantation, mice were
induced with NTN, and were killed at Day 8 after the
injection of nephrotoxic serum. WT bone marrow restored
disease susceptibility, as GLD mice transplanted with WT
bone marrow had more renal damage than GLD mice
transplanted with GLD bone marrow (Po0.05 for glomer-
ular thrombosis, crescents, serum urea, and urinary albumin/
creatinine ratios; Figure 7a–d). As noted in previous
experiments, there was no significant difference in the
glomerular macrophage infiltrate between any of the groups,
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but there were reduced interstitial macrophages, only in the
GLD to GLD transplants (not shown). Only the GLD to
GLD transplants had reduced levels of glomerular apoptosis
(Figure 7f).
However, our results suggest that FasL expression by
radioresistant cells in the kidney is also sufficient to induce
renal injury in NTN, as WT mice transplanted with GLD
bone marrow were not protected from NTN as compared
with WTmice transplanted with WT bone marrow (Figure 7).
To determine whether there was chimerism of resident
kidney leukocytes post bone marrow transplantation,
C57BL/6 (CD45.2) mice were transplanted with CD45.1
bone marrow using the same protocol. Ten weeks later,
kidney cells were dissociated, stained for CD45.1, CD45.2,
F4/80, and CD11c, and analyzed by flow cytometry (n¼ 7).
The chimerism of resident kidney cells was broadly similar to
blood with total leukocytes median 88% (range 87.3–91.8%),
CD11cþ F4/80þ 95.4 (92.3–95.6), and CD11cþ F4/80
93.4% (90.7–96.3%), Supplementary Figure S3 online. These
results suggest a role for intrinsic renal cell FasL in NTN
pathogenesis.
FasL mRNA increases in the kidney during NTN, and is
expressed by cultured mesangial cells
mRNA for FasL was increased in whole-kidney lysates after
the development of NTN, indicating that FasL in the kidney
itself could have a local effect (Figure 8a); however, the
mRNA results cannot distinguish whether this is originating
from circulating or intrinsic renal cells. We therefore assessed
the expression of FasL on mesangial cells, cultured overnight
in the presence of a metalloproteinase inhibitor to inhibit
cleavage to soluble FasL. By flow cytometry, we could detect
FasL on 18.4% of the cultured mesangial cells using a FasFc
conjugate, compared with 1.96% positive cells with the
secondary antibody alone (Figure 8b). As defective FasL
signaling has been associated with reduced responses to IL-1,
we then examined MCP-1 secretion by WT and GLD
mesangial cells after stimulation with IL-1 or TNF-a. There
was significantly reduced MCP-1 secretion by GLD mesangial
cells after stimulation with IL-1 but not TNF-a (representa-
tive results from one of five experiments for IL-1 and three
experiments for TNF-a are shown in Figure 8c and d).
DISCUSSION
Our results show that FasL mutant (GLD) mice on a C56BL/
6 background were strongly protected from histological and
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Figure 7 |Nephrotoxic nephritis in bone marrow-transplanted
mice at Day 8 after induction of NTN. (a) Glomerular thrombosis
score; (b) percentage glomerular crescents; (c) serum urea
(mmol/l); (d) urinary albumin/creatinine ratio (mg/mmol);
(e) Enzyme-linked immunosorbent assay (ELISA) for serum
anti-sheep immunoglobulin (Ig)G; (f) apoptotic bodies/glomerular
cross-section. Dashed lines refer to normal values for a group
of control wild-type (WT) mice. gcs, glomerular cross-section;
NTN, nephrotoxic nephritis; OD, optical density.
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functional renal injury, using the nephrotoxic nephritis
model of glomerulonephritis. T-cell-mediated systemic im-
munity was reduced in the early phase of the disease, which
may have contributed to protection from injury. However,
the bone marrow transplant results did not support an
exclusive role for FasL expressed by circulating cells in
mediating injury, making it less likely that differences in the
immune response are completely responsible for the protec-
tion of GLD mice from glomerulonephritis. We showed
expression of FasL in the kidney in NTN, and our results
would suggest that local expression of FasL in the kidney by
circulating or intrinsic renal cells can facilitate injury in this
model.
GLD mice have been found to be protected from a
number of models of injury.10,16–19 Similar to our findings,
T-cell proliferation to antigen was not reduced at the end
of the experiments in either collagen-induced arthritis10 or
experimental allergic encephalomyelitis.18 In these models,
the immune response at earlier stages of disease was not
examined.
A Th2-deviated immune response protects from murine
nephrotoxic nephritis.20 Th2-deviated immune responses have
been found in human patients with Fas and FasL muta-
tions causing autoimmune lymphoproliferative syndrome.11
We noted significantly increased IL-4 production by GLD
splenocytes after polyclonal stimulation (data not shown).
However, we could not demonstrate enhanced antigen-
specific Th2 responses systemically or in the kidney, and
thus this mechanism is unlikely to explain protection from
disease in our model.
Interestingly, there was no reduction in glomerular
macrophage or neutrophil infiltration into glomeruli in
GLD mice with NTN. Although FasL is involved in migration
of neutrophils6,7 and macrophages8 to inflammatory sites,
FasL does not have a major role in the entry of inflammatory
cells to glomeruli in this model. It is likely that other
mechanisms such as Fc receptor- or complement-mediated
events have a larger role in models in which immune
complexes are deposited.
It is striking that the glomerular injury and subsequent
interstitial injury and inflammation was markedly reduced,
despite the lack of reduction in glomerular macrophage
infiltration. This suggests that in the absence of functional
FasL, the ability of the cells to induce glomerular damage was
reduced. We saw reduced apoptotic bodies in the kidneys of
the GLD mice induced with NTN. FasL induces apoptosis of
cells, including mesangial cells.3 The reduction in apoptosis
may be responsible for protection from injury. An alternative
possibility is that the presence of FasL in the glomerulus is
involved in cell activation. Indeed, FasL has been reported to
function synergistically with IFN-g to enhance macrophage
activation.21 In addition, FasL can activate the intracellular
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mediator nuclear factor kappa B, a key transcription factor
for inflammatory responses,22 and facilitates signaling
through the IL-1 receptor.10 Binding of FasL to Fas activates
caspases, which process IL-1b for secretion.
Transplantation of WT bone marrow to GLD mice was
sufficient to restore susceptibility to NTN, indicating that
expression of FasL by circulating cells was sufficient to induce
NTN. However, transplantation of GLD bone marrow to WT
mice did not protect from disease, despite good deletion of
circulating WT bone marrow-derived cells. There were some
(B10%) WT circulating and intrinsic renal cells present in
these bone marrow transplants, and we cannot exclude the
possibility that these are sufficient to induce disease.
However, a lack of reduction of disease does suggest that
there is a source of FasL from radioresistant cells in the
kidney that is permissive for the development of NTN. This is
in contrast to results from similar experiments conducted in
experimental allergic encephalomyelitis and uveitis, where
FasL expressed on circulating cells was responsible for
protection from disease.19,23 We confirm that mesangial cells
in vitro express FasL. FasL on intrinsic renal cells is
functional, as there is a previous report of a functional role
for FasL expression by tubular cells in inducing apoptosis of
surrounding tubular cells in a model of cisplatin-induced
acute tubular necrosis.24 A role for FasL on intrinsic renal
cells in glomerulonephritis has not been previously shown.
GLD mesangial cells had attenuated responses to IL-1-b in
terms of the production of MCP-1 in vitro, consistent with
previous reports in other cell types expressing FasL.10,25
There was a large reduction in mRNA for MCP-1 in the GLD
kidneys, consistent with this finding, and a large reduction in
macrophages in the interstitium, which may indicate that
similar mechanisms operate to regulate MCP-1 production in
the interstitial compartment. MCP-1 is involved in cell
activation and chemotaxis.26
The autoimmunity-enhancing effects of FasL blockade
may preclude its use as a therapeutic agent. However, this
study highlights the importance of FasL in renal injury and
highlights a possible role for intrinsic renal cell FasL
expression in the pathogenesis of glomerulonephritis.
MATERIALS AND METHODS
Mice
GLD mice on a C57BL/6 background were purchased from Jackson
Laboratory (Maine, ME) and bred in-house, and C57BL/6 WTmice
were purchased from Harlan (Blackthorn, UK). Animal experiments
were conducted according to the institutional and the UK Home
Office guidelines. Mice were genotyped using a protocol available on
the Jackson Laboratory website. Experimental groups were matched
for sex and age.
Induction of nephrotoxic nephritis
Sheep anti-mouse nephrotoxic globulin was prepared as described
previously.27 The endotoxin content of the nephrotoxic globulin was
undetectable, measured using a Biowhittaker 1000-QCL LPS assay
kit (Biowhittaker, Walkersville, MD). Mice were immunized
intraperitoneally with 0.2mg of sheep IgG in a 50:50 mix of saline
and complete Freund’s adjuvant (Sigma Chemical, St Louis, MO).
Five days later, 0.2ml of nephrotoxic globulin was injected
intravenously. Mice were monitored clinically and the experiments
were terminated if the mice were showing signs of the disease.
Histological studies and quantitative immunofluorescence
Glomerular crescents and thrombosis were scored on samples fixed
in Bouin’s solution and stained with periodic acid-Schiff, by an
observer blinded to the experimental group. Glomerular thrombosis
was assessed by scoring individual glomeruli for periodic acid-
Schiff-positive material as follows: grade 0: no periodic acid-Schiff-
positive material; grade 1: 0–25% of glomerular cross-section
periodic acid-Schiff positive; grade 2: 25–50%; grade 3: 50–75%;
grade 4: 75–100%. Fifty glomeruli were scored per kidney.
Glomerular crescents were defined as glomeruli containing two or
more layers of cells in Bowman’s space.
Glomerular mouse and sheep IgG were visualized by direct
immunofluorescence on frozen kidney sections using fluorescein
isothiocyanate-conjugated goat anti-mouse IgG (Fc-specific) and
fluorescein isothiocyanate-conjugated monoclonal mouse anti-sheep
IgG clone GT34 (Sigma, Dorset, UK). To quantify immunofluores-
cence, sections were examined at  40 magnification using an
Olympus BX4 fluorescence microscope (Olympus Optical, London,
UK) and a Photonic Science Colour Coolview camera (Photonic
Science, Robertsbridge, UK). Samples from each experiment were
stained on the same occasion and measured together. Images of the
sections were captured using Image Pro (MediaCybernetics,
Bethesda, MD) and the total pixel intensity for each glomerulus
was measured and averaged for 20 glomeruli per section.
For cell markers, kidneys were fixed in periodate-lysine-
paraformaldehyde. Sections of 5 mm were stained for macrophages
with FA11 (monoclonal rat anti-mouse CD68, Serotec, Oxford, UK)
or CD4 cells (GK1.5, BDPharmingen, Oxford, UK), and developed
using the Polink-2 plus HRP rat detection kit (Newmarket Scientific,
Newmarket, UK). Macrophages and T cells in 50 glomeruli/sample
were counted and averaged to obtain cells/glomerular per cross-
section. For interstitial macrophage infiltration, five high-power
fields per kidney were photographed. The proportion of the pictures
with brown peroxidise pigmentation was calculated using the
ImagePro software (MediaCybernetics) and averaged for the five
high-power fields. All slides from a single experiment were analyzed
simultaneously TUNEL staining was used to detect apoptotic cells
on formalin-fixed sections of mouse kidney using the ApopTag
Fluorescein Kit (Qbiogene, Carlsbad, CA).
Quantitative RT-PCR
Total RNA was extracted from whole kidneys using the TRIzol
method. Real-time qRT-PCR was performed on an ABI 7500
Sequence Detection System (Applied Biosystems, Warrington, UK)
using Brilliant II SYBR Green qRT-PCR Master Mix, 1 Step
(Stratagene, Cambridge, UK). RNAwas used at a final concentration
of 5–10 ng/ml and all samples were run in duplicates. Results were
exported to the 7500 Fast System SDS software (Applied Biosystems),
and Ct values were determined for all the genes analyzed. The
relative expression levels, normalized to GAPDH gene expression,
were determined by using the 2DDCt method. The following
primers were used: MCP-1 forward: 50-ATGCAGTTAATGCCC
CACTC-30; MCP-1 reverse: 50-AGCTGGAAGCCACTGACACT-30;
GAPDH forward: 50-GGGTGTGAACCACGAGAAAT-30; GAPDH
reverse: 50-GTCTTCTGGGTGGCAGTGAT-30; IFN-g forward: 50-GCA
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TCTTGGCTTTGCAGCTC-30; IFN-g reverse: 50-CGACTCC
TTTTCCGCTTCCT-30; IL-4 forward: 50-ACAGGAGAAGGGACGC
CAT-30; IL-4 reverse: 50-GAAGCCCTACAGACGAGCTCA; IL-12-
p40 forward: 50-GGAAGCACGGCAGCAGAATA-30; IL-12-p40
reverse: 50-AACTTGAGGGAGAAGTAGGAAT-30; FasL forward:
50-ACCCCCACTCAAGGTCCAT-30; FasL reverse: 50-CGAAGTAC
AACCCAGTTTCGT-30.
Serum urea, albumin, and urinary albumin/creatinine ratio
Serum urea and urinary creatinine were measured in the Depart-
ment of Clinical Chemistry, Imperial College Healthcare NHS Trust.
Serum albumin was measured using the AssayMax mouse albumin
ELISA kit (AsssayPro, St Charles, MO). Albuminuria was assessed by
radial immunodiffusion against a rabbit anti-mouse albumin
(Biogenesis, Poole, UK), as previously described.27
Circulating antibody and T-cell immune responses
Serum mouse anti-sheep IgG levels were measured by sandwich
ELISA as previously described.27 Detecting antibody for IgG
(g-chain specific) was obtained from Sigma. Samples were tested
in duplicate at 1:500 and 1:1000 dilutions. Background fluorescence
in uncoated wells was subtracted, and normal serum from
unimmunized mice served as a control.
For splenocyte proliferation assays, single-cell suspensions were
created and red cells were lysed. Cells were cultured at 1 106 cells/ml
for 72 h in HL1 serum-free medium (Lonza, Basel, Switzerland), in
the presence or absence of 100 ng/ml heat-aggregated sheep IgG, or
100 ng/ml phorbol myristate acetate plus ionomycin (500 ng/ml) as
a positive control. At 72 h, 1 mCi/well 3H thymidine was added for
24 h before assessing splenocyte proliferation using standard
procedures and a Wallac 1450 microbeta counter (Perkin Elmer,
Waltham, MA). Supernatants collected at 72 h were assayed for IL-4
and IFN-g using ELISA kits, according to the manufacturer’s
instructions (eBioscience, Hatfield, UK), and IL-17alpha (R&D
Systems, Minneapolis, MN). Lower limits for detection were 1, 15,
and 15 pg/ml.
Bone marrow chimeras
Chimeric mice were made by irradiation with a dose of 8Gy and
reconstituted with 10 106 donor bone marrow cells. Nephritis
experiments were conducted at 10 weeks after this. Confirmation of
chimerism was obtained using PCR on DNA extracted from 0.1ml
blood obtained at the terminal bleed. PCR was performed as
recommended on the Jackson laboratory website, except that the
reverse primer was labeled with the fluorescent marker 6-carboxy-
fluoroscein. The products were run on Genescan (Applied
Biosystems) and the ratio of the mutant (108 bp) versus WT
(88 bp) product was calculated and compared with known mixtures
of WT and GLD DNA (0, 5, 50, 90, 95, and 100% mutant DNA). In
addition, to confirm chimerism, blood was taken from mice
transplanted with CD45.1 allotype bone marrow and the mice were
bled at 10 weeks post transplantation. Red cells were lysed, and Fc
receptors were blocked with 2.4G2 and stained with CD45.1 APC
and CD45.2 APC. Kidney single-cell suspensions were prepared as
previously described.28 Briefly, kidneys were removed and sliced into
six pieces using a scalpel, followed by digestion with DNase I 100
and 0.5 mg/ml Collagenase D (Roche Diagnostics, Burgess Hill, UK).
Kidneys were mashed and filtered through a 100-mm nylon mesh.
Kidney suspensions were incubated with 2.4G2 (eBiosciences) to
block Fc receptors, and then stained with the following antibodies
obtained from eBiosciences: APC-CD45.1, PE-CD45.2, fluorescein
isothiocyanate F4/80, and PerCP Cy5.5 CD11c. Flow cytometry was
performed using a FACScalibur flow cytometer and analyzed using
the FlowJo (TreeStar, Ashland, OR) software.
Mesangial cell cultures
Glomeruli were collected from WT and GLD kidneys and digested
with collagenase as previously described.29 Mesangial cells were
cultured in RPMI containing 20% fetal calf serum, and passaged
8–12 times before use. Mesangial cells were characterized as anti-
myosin positive, CD11b, and pancytokeratin negative, with
characteristic stellate morphology. Briefly, 106 cells/well were
cultured in a six-well plate (Nunc, Rochester, NY) for 24 h, after
which the cells were serum-starved overnight. Cells were stimulated
with 10 ng/ml IL-1b, TNF-a, or left unstimulated in serum-free
mesangial media for 24 h. Supernatant MCP-1 levels were
analyzed by ELISA according to the manufacturer’s instructions
(eBioscience). Cytokine levels were corrected for cell numbers and
were compared with the end of the experiment using the MTT assay
according to the manufacturer’s instructions (Sigma). There tended
to be more cells in the GLD wells at the termination of the
experiments, possibly because of reduced apoptosis in these cells.
Mesangial cell FasL expression
Mesangial cells were cultured in the presence of 10mmol/l GM6001
(Sigma) for 24h before collecting (protease inhibitor to prevent
cleavage of membrane-bound FasL). Cells were collected using
Cell Dissociation Solution (Sigma), and nonspecific binding
was blocked using 10% normal mouse serum. A measure of 1mg
FasFc conjugate (Sigma) was added to 0.5 106 cells, followed by
washing in phosphate-buffered saline/1% fetal calf serum. Bound FasFc
was detected using fluorescein isothiocyanate-conjugated antihuman
IgG (Sigma). Flow cytometry was performed using a FACSCalibur flow
cytometer and analyzed using the FlowJo (TreeStar) software.
Statistics
Results are quoted as median (interquartile range), unless otherwise
stated. Lines on graphs represent median value. For comparing two
groups, the Mann–Whitney U-test was used, and for three or more
groups a one-way analysis of variance with Bonferroni’s post test
was used. GraphPad Prism (GraphPad Software, San Diego, CA) was
used to analyze the data. Differences were considered significant
when Po0.05.
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SUPPLEMENTARY MATERIAL
Figure S1. Histology from unmanipulated WT and GLD mice at
2 months and 4 months of age.
Figure S2. Functional and histological parameters at Day 8 after
induction of NTN in wild-type (WT) and GLD mice.
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Figure S3. A-B: Flow cytometry of blood and kidney leukocytes
10 weeks post bone marrow transplantation, to demonstrate the
degree of chimerism.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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